These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8227495)

  • 1. Upjohn answers Consumer Reports.
    Olanoff LS
    J Clin Psychopharmacol; 1993 Oct; 13(5):361-3. PubMed ID: 8227495
    [No Abstract]   [Full Text] [Related]  

  • 2. Upjohn responds to Consumer Reports letter.
    Jonas JM
    J Clin Psychopharmacol; 1994 Aug; 14(4):289-90; author reply 291-2. PubMed ID: 7962694
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug treatment of panic disorder. Reply to comment by Marks and associates.
    Klerman GL
    Br J Psychiatry; 1992 Oct; 161():465-71. PubMed ID: 1309180
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to "high anxiety".
    Piper A
    J Clin Psychopharmacol; 1994 Aug; 14(4):290-2. PubMed ID: 7962695
    [No Abstract]   [Full Text] [Related]  

  • 5. Subjective experience and attitudes towards participation in clinical trials among patients with anxiety disorders.
    Klein E; Malel D; Zilberman I; Lenox RH
    Isr J Psychiatry Relat Sci; 1997; 34(4):265-9. PubMed ID: 9409083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
    Jonas JM; Cohon MS
    J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
    Klein E; Colin V; Stolk J; Lenox RH
    Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDMA ("ecstasy") and panic disorder: induction by a single dose.
    McCann UD; Ricaurte GA
    Biol Psychiatry; 1992 Nov; 32(10):950-3. PubMed ID: 1361366
    [No Abstract]   [Full Text] [Related]  

  • 10. Method for assessing the duration of therapeutic action and milligram equivalence of anxiolytics.
    Sheehan DV; Raj AB; Harnett-Sheehan K; Dorotheo J; Sheehan MF; Trehan R; Knapp E; Swiontek A; Coleman B
    Anxiety; 1996; 2(1):40-6. PubMed ID: 9160598
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors of individual differences in alprazolam self-medication.
    Oswald LM; Roache JD; Rhoades HM
    Exp Clin Psychopharmacol; 1999 Nov; 7(4):379-90. PubMed ID: 10609973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin as a potential treatment for anxiety disorders.
    Pollack MH; Matthews J; Scott EL
    Am J Psychiatry; 1998 Jul; 155(7):992-3. PubMed ID: 9659873
    [No Abstract]   [Full Text] [Related]  

  • 13. Xanax: pros and cons.
    Glod CA
    J Psychosoc Nurs Ment Health Serv; 1992 Jun; 30(6):36-7. PubMed ID: 1613686
    [No Abstract]   [Full Text] [Related]  

  • 14. [The efficacy of alprazolam in the therapy of panic disorders].
    Diukova GM; Vorob'eva OV; Petrova EP; Smirnov SV; Tumalaeva ZN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(4):9-13. PubMed ID: 8533521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of response to alprazolam and placebo in patients with panic disorder.
    Woodman CL; Noyes R; Ballenger JC; Lydiard RB; Sievers G; Mihalko D
    J Affect Disord; 1994 Jan; 30(1):5-13. PubMed ID: 8151049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatment of panic disorder. Further comment.
    Marks IM; Başoğlu M; Noshirvani H; Greist J; Swinson RP; O'Sullivan G
    Br J Psychiatry; 1993 Jun; 162():795-6. PubMed ID: 8380006
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
    Klein E; Zinder O; Colin V; Zilberman I; Levy N; Greenberg A; Lenox RH
    Acta Psychiatr Scand; 1995 Dec; 92(6):399-408. PubMed ID: 8837965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB; Laraia MT; Ballenger JC; Howell EF
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP; Pecknold JC; Kuch K
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):105-13. PubMed ID: 3628823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.